• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Sanofi S.A. (Euronext: SAN, Nasdaq: SNY)

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). *

 

	Start	2011-05-06 renamed
	Group	Sanofi (Group) [since May 2011]
	Predecessor	Sanofi-Aventis S.A. (EURONEXT: SAN, NYSE: SNY)
	Industry	pharmaceutical
	Person	Brandicourt, Olivier (Sanofi 201508–201908 CEO before CEO of Bayer HealthCare before Pfizer Inc RETIRED 9/19)
	Person 2	Contamine, Jérôme (Sanofi 2009–201809 CFO RETIRED 9/18)
	Region	Paris
	Country	France
	Street	174 avenue de France
	City	75635 Paris Cedex 13
	Tel	+33-1-5377-4000
		Address record changed: 2020-12-02
Basic data	Employees	I: 50,001 to 100,0 (2019-02-06)
	Currency	EUR
	Annual sales	34,463,000,000 (sales, net, consolidated (2018) 2018-12-31)
	Profit	4,410,000,000 (2018-12-31)
	Cash	2,633,000,000 (2018-12-31)
		* Document for �About Section�:
		Record changed: 2021-01-12

Advertisement

More documents for Sanofi (Group) [since May 2011]

• [1] Sanofi S.A.. (1/11/21). "Press Release: Sanofi to Acquire Kymab, Adding KY1005 to Its Pipeline, a Human Monoclonal Antibody Targeting Key Immune System Regulator OX40L". Paris & Cambridge....
• [2] Jeito Capital. (11/13/20). "Press Release: Sanofi Selects Jeito Capital as Its First Investment into a Private French-based Fund". Paris....
• [3] Kiadis Pharma N.V.. (11/2/20). "Press Release: Sanofi Offers to Acquire Kiadis for €308 Million". Paris & Amsterdam....
• [4] Sanofi S.A.. (8/17/20). "Press Release: Sanofi to Acquire Principia Biopharma". Paris & South San Francisco, CA....
• [5] GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK in Advanced Discussions with European Union to Supply up to 300 Million Doses of COVID-19 Vaccine". London & Paris....
• [6] GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK Selected for Operation Warp Speed to Supply United States Government with 100 Million Doses of COVID-19 vaccine". London & Paris....
• [7] Kymera Therapeutics Inc.. (7/9/20). "Press Release: Kymera Therapeutics and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Advance Novel Protein Degrader Therapies to Patients". Cambridge, MA....
• [8] Kiadis Pharma N.V.. (7/8/20). "Press Release: Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs to Sanofi, with Total Potential Deal Value of €875 Million, plus Royalties". Amsterdam....
• [9] Sanofi S.A.. (5/29/20). "Press Release: Sanofi Announces Closing of Regeneron Stock Sale". Paris....
• [10] Sanofi S.A.. (5/27/20). "Press Release: Sanofi Announces Pricing of Regeneron Stock Offering". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.